ReviewCell death & disease2026
Cristae: bridging bioenergetic hubs and compartmental barriers in mitochondrial homeostasis.
Review in Cell death & disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Modulation of innate and adaptive immunity by pH-responsive nanozyme-like nanoparticles with high mobility for rheumatoid arthritis alleviation.Bioactive materials · 2026Article
- CHCHD3(MIC19): mitochondrial cristae structure regulation and disease associations.Frontiers in molecular biosciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mitochondrial cristae are intricately folded structures of the inner mitochondrial membrane that play essential roles in cellular energy production, metabolic regulation, and compartmentalization. Far from being passive folds, cristae are dynamic, functional entities central to mitochondrial bioenergetics. Their architecture maximizes membrane surface area and spatially organizes protein complexes to enhance oxidative phosphorylation and adenosine triphosphate (ATP) synthesis. The compartmentalized structure of cristae also establishes functional barriers that help maintain localized proton gradients, optimize metabolic reactions, and contribute to mitochondrial stability. These dual roles in energy transformation and spatial segregation underscore the importance of the cristae in supporting cellular homeostasis. The structural design and lipid composition of cristae with enrichment in cardiolipin also reflect their bacterial ancestry, revealing an evolutionary continuity from prokaryotic bioenergetic systems to eukaryotic organelles. Moreover, dynamic remodeling of cristae in response to stress, nutrient availability, and developmental cues highlights their adaptability in regulating mitochondrial performance and signaling pathways. Disruption of cristae architecture is increasingly implicated in neurodegenerative, cardiovascular, and metabolic diseases due to impaired ATP synthesis and compromised mitochondrial integrity. This review examines emerging insights into the organization, composition, and regulatory mechanisms of the cristae, emphasizing their role as both bioenergetic engines and protective compartments. Understanding the complex interplay between cristae structure and mitochondrial function may illuminate novel strategies for restoring mitochondrial health and targeting diseases linked to mitochondrial dysfunction. Cristae represent an evolutionary innovation that bridges structure and function, enabling the mitochondria to meet the multifaceted demands of the eukaryotic cell.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.